TY - JOUR
T1 - Challenges and opportunities in cancer control in Africa
T2 - A perspective from the African Organisation for Research and Training in Cancer
AU - Morhason-Bello, Imran O.
AU - Odedina, Folakemi
AU - Rebbeck, Timothy R.
AU - Harford, Joe
AU - Dangou, Jean Marie
AU - Denny, Lynette
AU - Adewole, Isaac F.
N1 - Funding Information:
These consortia work collaboratively with AORTIC to advance cancer research in Africa, and are supported by the US National Cancer Institute Epidemiology and Genetics Research Program. Additionally, AORTIC works closely with the US National Cancer Institute to implement the Beginning Investigator Grant for Catalytic Research (Big Cat) grant programme for African researchers.
PY - 2013/4
Y1 - 2013/4
N2 - Sub-Saharan Africa has a disproportionate burden of disease and faces a major public-health challenge from non-communicable diseases. Although infectious diseases continue to afflict Africa, the proportion of the overall disease burden in sub-Saharan Africa attributable to cancer is rising. The region is predicted to have a greater than 85% increase in cancer burden by 2030. Approaches to minimise the burden of cancer in sub-Saharan Africa in the past few years have had little success because of low awareness of the cancer burden and a poor understanding of the potential for cancer prevention. Success will not be easy, and will need partnerships and bridges to be built across countries, economies, and professions. A strategic approach to cancer control in sub-Saharan Africa is needed to build on what works there and what is unique to the region. It should ideally be situated within strong, robust, and sustainable health-care systems that offer quality health care to all people, irrespective of their social or economic standing. However, to achieve this will need new leadership, critical thinking, investment, and understanding. We discuss the present situation in sub-Saharan Africa and propose ideas to advance cancer control in the region, including the areas of cancer awareness, advocacy, research, workforce, care, training, and funding.
AB - Sub-Saharan Africa has a disproportionate burden of disease and faces a major public-health challenge from non-communicable diseases. Although infectious diseases continue to afflict Africa, the proportion of the overall disease burden in sub-Saharan Africa attributable to cancer is rising. The region is predicted to have a greater than 85% increase in cancer burden by 2030. Approaches to minimise the burden of cancer in sub-Saharan Africa in the past few years have had little success because of low awareness of the cancer burden and a poor understanding of the potential for cancer prevention. Success will not be easy, and will need partnerships and bridges to be built across countries, economies, and professions. A strategic approach to cancer control in sub-Saharan Africa is needed to build on what works there and what is unique to the region. It should ideally be situated within strong, robust, and sustainable health-care systems that offer quality health care to all people, irrespective of their social or economic standing. However, to achieve this will need new leadership, critical thinking, investment, and understanding. We discuss the present situation in sub-Saharan Africa and propose ideas to advance cancer control in the region, including the areas of cancer awareness, advocacy, research, workforce, care, training, and funding.
UR - http://www.scopus.com/inward/record.url?scp=84875802416&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875802416&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(12)70482-5
DO - 10.1016/S1470-2045(12)70482-5
M3 - Review article
C2 - 23561745
AN - SCOPUS:84875802416
SN - 1470-2045
VL - 14
SP - e142-e151
JO - The Lancet Oncology
JF - The Lancet Oncology
IS - 4
ER -